tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Newron Pharmaceuticals SpA (NWPHF)
OTHER OTC:NWPHF
US Market
NWPHF
Newron Pharmaceuticals SpA
RESEARCH TOOLSreports

Newron Pharmaceuticals SpA (NWPHF) Stock News & Sentiment

Compare
11 Followers
Newron bolsters finances as Evenamide enters pivotal global Phase III
Premium
Company Announcements
Newron bolsters finances as Evenamide enters pivotal global Phase III
4h ago
Newron Fortifies Evenamide Phase III Push with Fresh Capital, Patent Win and Board Overhaul
Premium
Company Announcements
Newron Fortifies Evenamide Phase III Push with Fresh Capital, Patent Win and Board Overhaul
4h ago
Newron to Highlight Phase III Evenamide Data at 2026 Schizophrenia Congress
Premium
Company Announcements
Newron to Highlight Phase III Evenamide Data at 2026 Schizophrenia Congress
4d ago
Newron extends EIB loan maturities to align financing with Evenamide milestones
Premium
Company Announcements
Newron extends EIB loan maturities to align financing with Evenamide milestones
5d ago
Newron refreshes board with CNS and capital markets experts ahead of AGM
Premium
Company Announcements
Newron refreshes board with CNS and capital markets experts ahead of AGM
6d ago
Newron Raises Up to EUR 38 Million to Advance Phase III Schizophrenia Drug Evenamide
Premium
Company Announcements
Newron Raises Up to EUR 38 Million to Advance Phase III Schizophrenia Drug Evenamide
1M ago
Newron Raises Up to EUR 38 Million to Advance Phase III Schizophrenia Drug
Premium
Company Announcements
Newron Raises Up to EUR 38 Million to Advance Phase III Schizophrenia Drug
1M ago
More NWPHF News >

NWPHF News on the Web

Newron extends EIB loan maturities to align financing with Evenamide milestones
TipRanks News
Bullish
Newron refreshes board with CNS and capital markets experts ahead of AGM
TipRanks News
Bullish
Newron Raises Up to EUR 38 Million to Advance Phase III Schizophrenia Drug Evenamide
TipRanks News
Bullish
Newron Raises Up to EUR 38 Million to Advance Phase III Schizophrenia Drug
TipRanks News
Bullish
Analysts Conflicted on These Healthcare Names: Arcturus Therapeutics (ARCT), Newron Pharmaceuticals SpA (OtherNWPHF) and Aldeyra Therapeutics (ALDX)
TipRanks News
Bullish
Newron Pharma price target raised to CHF 43 from CHF 26 at H.C. Wainwright
TipRanks News
Bullish
Newron Secures EU Patent Extension for Lead Schizophrenia Drug Evenamide
TipRanks News
Bullish
Newron Wins Long-Term EU Patent Protection for Lead Schizophrenia Drug Evenamide
TipRanks News
Bullish

News Score - Last 7 Days

Positive
NWPHF
Sector Average
Media Buzz
This Week2 articles
Weekly Average1 articles
News Sentiment
This Week100%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NWPHF’s Media Buzz Sentiment?
2 articles about NWPHF were published this week. In an average week, 1 articles are published.
    What is NWPHF’s weekly average amount of articles?
    In an average week, 1 articles about NWPHF are published.
      What is NWPHF’s News Sentiment?
      100% of articles about NWPHF were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        HYPRHyperfine
        OVIDOvid Therapeutics
        INNMFAmplia Therapeutics
        ALMSAlumis Inc.
        NWPHFNewron Pharmaceuticals SpA
        Showing the stocks with the most bullish news sentiment over the past week